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Red grain sorghum whole kernel crude lipid protects energy 
metabolism and short chain fatty acid profile in a hamster model 
to minimize intestinal stress caused by a high fat diet 
Haowen Qiu, M.S. 
University of Nebraska, 2017 
Advisor: Vicki Schlegel 
Multiple studies have shown throughout the past 10+ years that grain sorghum (GS) lipid 
extract protects against high plasma and hepatic cholesterol and, to a lesser degree, positively 
modulate the gut microbiota in response to a high fat (HF) diet. However, the impact of GS lipids 
on intestinal stress induced by such a diet remains largely unknown. The objective of this project 
was to determine the ability of GS crude lipid (GS-CL) obtained from the surface of GS whole 
kernel to protect energy metabolism and short chain fatty acid (SCFA) profile produced by the 
gut microbiome that may be negatively affected by a HF diet. If left unchecked, such impacts can 
lead to hypoxia or inflammation and thereby other chronic conditions. In our study, male 
hamsters were fed with either a low fat control diet, a HF diet or a HF diet supplemented with 1, 
3, 5% (w/w) GS-CL for four weeks. The hamsters were then euthanized and the large intestine 
obtained and analyzed using targeted metabolomics. Analysis of central carbon metabolites 
showed that the HF diet impaired energy generation and disrupted cellular redox balance. A 
significant increase of many intermediates of glycolysis (particularly glyceraldehyde-3-
phosphate, glycerate-3-phosphate and phosphoenolpyruvate) and tricarboxylic acid (TCA) cycle 
(particularly succinate, fumarate and malate) occurred in response to a HF influence, while nearly 
all amino acids were significantly lower compared to the low fat diet. The GS-CL supplements 
were able to maintain energy levels in the large intestine, especially the 1 and 3% but were not 
able to rebalance redox equilibrium completely. Moreover, multivariant analysis including 
orthogonal-partial least squares-discrimination analysis (OPLS-DA) demonstrated that the GS-CL 
 
 
 
 
supplements were able to gradually maintain the HF affected metabolites to levels trending or 
comparable to the control level, with 3% supplement being the optimal diet in this regard. In 
general, the data indicated that the GS-CL supplements slowed down the gluconeogenesis and 
anaplerosis from pyruvate and amino acids, which in turn mitigated the accumulation of 
glycolysis and TCA intermediates in a dose-depended manner. In addition, the GS-CL 
supplements positively affected the short chain fatty acid (SCFA) produced by large intestine 
microbiome, with the 3% diet again exerting the optimal protection, against HF induced changes 
in SCFA profile followed by 1% supplement. Synergistic interaction among various components 
in GS-CL (such as the characterized phytosterols and policosanols) may be responsible for some 
of the metabolic responses as the effects of GS-CL is optimal compared to that reported of the GS 
oil or wax fraction alone. This study is the first to provide whole-scale impact of GS-CL on 
cellular energy and central carbon metabolism using a combined approach of metabolomics and 
multivariant analysis, which effectively demonstrate the potentials of GS-CL as a supplement to 
prevent or contain chronic metabolic diseases.  
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1. Literature review 
I. Introduction to grain sorghum (GS)  
Sorghum (Sorghum bicolor (L.) Moench), in the form of a grain, forage or sugar crop, is 
the fifth most important cereal in the world succeeded only by wheat, rice, maize and barley 
(Althwab, Carr, Weller, Dweikat, & Schlegel, 2015). Currently, sorghum is widely cultivated in 
more than 30 countries due to its tolerance to temperature and moist fluctuations, thereby 
providing food for over 500 million people (Rooney, et al., 2010). For the United States, grain 
sorghum (GS) acreage has ranged from 15 to 18 million acres per year during the past 25 years 
(Carter, et al., 2016), which is slightly greater than land dedicated to oat and barley production. In 
2011, the U.S was the No. 1 exporter and the No. 2 producer (behind Nigeria) of GS with Kansas, 
Arkansas, Nebraska, Colorado and Missouri being the primary GS growers among the 21 states 
that produce sorghum according to the U.S. Department of Agriculture (2016).  
Yet, GS has been mainly used as animal feeds in the U.S., but more recently interest has 
been growing in employing GS as a source for biofuel production (Wang, Weller, & Hwang, 
2005). This lack of GS consumption in the U.S. is regrettable as GS contains a unique 
phytochemical profile, including phenolic acids, condensed tannins, anthocyanins, policosanols 
and phytosterols (Awika & Rooney, 2004). Indeed, numerous studies on these compounds using 
both an in vitro and in vivo approaches have shown their antioxidant and anti-inflammatory 
effects as well as their health benefiting properties on weight control, glycemic control and gut 
microbiota as will be discussed in the next sections of this chapter.  
A. Composition and potential health benefits of grain sorghum 
Grain sorghum provides a rich source of health promoting agents (nutraceuticals) for the 
human diet. The main components present in GS include starch (~75%), protein (~12%), lipids 
(~4%), fiber (~7%) and several minerals and vitamins (Althwab, Carr, Weller, Dweikat, & 
Schlegel, 2015) (Stefoska-Needham, Beck, Johnson, & Tapsell, 2015). Additionally, GS 
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possesses a unique phytochemical profile, including ample types of phytosterols, policosanols 
and phenolic compounds, which are often considered the components responsible for the many 
health benefits associated with GS (Awika & Rooney, 2004) (de Morais Cardoso, Pinheiro, 
Martino, & Pinheiro-Sant'Ana, 2017).   
i. Antioxidant 
Grain sorghum exhibits significantly antioxidant activity as reported throughout the 
literature. For example, feeding high tannin sorghum to rats reduced markers of protein oxidation 
in the muscle without affecting animal growth (Larrain, Richards, Schaefer, & Reed, 2007). 
During colon carcinogenesis, rats fed a black sorghum bran diet presented with increased activity 
of colon-based superoxide dismutase (SOD), while rats fed white sorghum bran exhibited 
elevated catalase (CAT) activity. These results indicate that the sorghum diet is able to increase 
key endogenous antioxidant enzymes to protect against oxidative stress (Lewis, et al., 2008). 
Oboh et al. (2010) also confirmed the antioxidant properties of sorghum by demonstrating the 
neuroprotective effect of a red dye fraction obtained from a sorghum extract against 
cyclophosphamide-induced oxidative stress using a rat clinical model. The protective effect was 
attributed to the antioxidant activities exerted by the high phenolic components present in the red 
dye. In addition, cisplatin-induced nephrotoxicity and hepatotoxicity were remediated by a 
sorghum straw and a leaf sheath dye supplement, respectively, which occurred by reversing 
elevated plasma, kidney and liver antioxidant indices (Ademiluyi, Oboh, Agbebi, & Oyeleye, 
2014). Moreover, Ajiboye et al. (2013) demonstrated that a sorghum phenolic rich extract 
protected rat microsomes against diethylnitrosamine (DEN)-induced redox imbalance by 
significantly attenuating a DEN-mediated decrease in the activities of redox oxygen species 
(ROS) detoxifying enzymes. Recently, a human clinical trial using healthy subjects studied the 
antioxidative effect of consuming pasta containing sorghum flour. The sorghum treated group 
presented with significantly higher plasma polyphenols, antioxidant capacity, SOD activity and 
lower protein carbonyl levels compared to control group, indicating an enhanced antioxidant 
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status and improved markers of oxidative stress (Khan, Yousif, Johnson, & Gamlath, 2015). 
Lastly, Cruz et al. (2015) showed that a sorghum kafirin extract resulted in higher proportion of 
α-kafirin monomers and hydrophobic amino acid content, which in turn has been linked to 
improved lipid metabolism and increased serum antioxidant potential in rats. 
ii. Anti-inflammation 
Reports have further shown that GS exerts anti-inflammatory effects, which again has 
been attributed to the presence of a variety of phytochemicals, especially those present in the 
bran. One such study compared the impact of hyaluronidase, which has been correlated with 
chronic inflammation, in response to extracts obtained from wheat and rice bran and from brans 
originating from six varieties of sorghum  (Bralley, Greenspan, Hargrove, & Hartle, 2008). The 
sorghum extracts were more effective in inhibiting hyaluronidase activity in vitro compared to its 
counterparts. The responses were positively correlated to total phenolic content and ferric 
reducing antioxidant power values. The researchers proposed that this inhibitory effect supports 
the development of sorghum bran as an anti-inflammatory nutraceutical (Bralley, Greenspan, 
Hargrove, & Hartle, 2008). Burdette et al. (2007; 2010) also tested the anti-inflammatory effect of 
sorghum bran extracts in a 12-O-tetradecanoylphorbol acetate (TPA)-induced ear edema rat 
model. The extract of black sorghum bran significantly decreased ear thickness and weights of 
ear punches after TPA treatment in addition to inhibiting the secretion of the pro-inflammatory 
cytokines interleukin 1-beta (IL-1β) and tumor necrosis factor alpha (TNF-α) (Burdette, 
Hargrove, Hartle, & Greenspan, 2007) (Burdette, et al., 2010). Another study using the extract of 
golden gelatinous sorghum bran showed that the expression level of cyclooxygenase 2 (COX-2) 
and inducible nitric oxide synthase (iNOS) induced by 12-O-tetradecanoylphorbol-13-acetate 
(TPA) were inhibited in a rat model (Shim, Kim, Jang, Ko, & Kim, 2013). Additionally, Hartle, 
Greenspan, and Hargrove (2011) showed that the anti-inflammatory activity of the black sorghum 
brans correlated with their phenolic content and antioxidant activity. Ritchie et al. (2011) also 
reported that a black sorghum bran containing diet was able to remediate dextran sulfate sodium 
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(DSS)-induced colonic inflammation and reduce the activation of the pro-inflammatory 
transcription factor nuclear factor kappa B (NF-κB) in rats. It has been proposed that black 
sorghum bran is able to protect against inflammation by altering the colon microbiota (Ritchie L. 
E., Carroll, Weeks, Rooney, & Turner, 2012), species diversity, species richness (Ritchie, et al., 
2015) and the beneficial secondary metabolites produced by the microbiome (Ritchie, Sturino, 
Azcarate-Peril, & Turner, 2013). 
Other fractions of sorghum have also been reported to reduce inflammation at both the 
cellular and the animal level. For example, aqueous and non-aqueous fraction of sorghum leaf 
sheaths reduced ROS formation by inflammatory polymorphonuclear (PMN) cells and the 
migration of these cells in response to the inflammatory chemoattractant leukotriene B4, with the 
ethanol fraction inducing a similar effect (Benson, et al., 2013). Other research demonstrated that 
a chloroform fraction of GS almost completely suppressed the lipopolysaccharide (LPS)-induced 
production of nitric oxide (NO), TNF-α and interleukin 6 (IL-6) (Hwang, et al., 2013). As a major 
constituent of GS, caffeoylglycolic acid methyl ester (CGME) was reported to exert anti-
inflammatory effects by inducing heme oxygenases (HO)-1 expression via the nuclear factor-E2-
related factor 2 (Nrf2)/heme oxygenase-1 pathway (Choo, et al., 2015). Caffeoylglycolic acid 
methyl ester (CGME) along with benzoic and cinnamic acid derivatives from GS also inhibited 
the production of NO and prostaglandin E2 (PGE2), IL-6 as well as the expression of iNOS, COX-
2 and IL-6 in LPS-stimulated RAW 264.7 cells (Nguyen, et al., 2015) (Choo, et al., 2015).  
B. Grain sorghum lipid profile and health benefits 
The GS whole kernel contains high levels of lipid (3.0-4.9%), comparable or higher than 
many other cereal crops, such as corn (4.74%), wheat (1.71%), barley (1.16%) and rice (0.58%) 
(Hwang, Kim, & Weller, 2005). Serna-Saldivar and Rooney (1994) showed that the germ of GS 
contains the highest level of lipid (76.2%) followed by the endosperm (13.2%) and the pericarp 
(10.6%).  
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The lipid extract from the whole kernel, i.e., the lipid coating the surface of the kernel, 
has been analyzed by Carr et al. (2005) using thin layer chromatography (TLC, Figure 1). The 
lipid extract from whole kernel possesses a unique compositional profile, containing 
hydrocarbons, steryl esters, wax esters, aldehydes, alcohols, triacylglycerol, diacylglycerol, 
monoacylglycerol, free fatty acids and free sterols (Figure 2). This GS crude lipid (GS-CL) is 
composed of a wax and an oil fraction at a 2:1 or 3:1 basis (Lee, et al., 2014) (Wang, Weller, & 
Hwang, 2005). Hwang et al. (2002) showed that the wax fraction was composed of 46.3% fatty 
aldehydes, 7.5% fatty acids, 41.0% fatty alcohols, 0.7% hydrocarbons, 1.4% wax esters and steryl 
esters and 0.9% triacylglycerol. Alternatively triacylglycerols (~90%) were the most abundant 
compounds in the oil fraction as shown by Lee et al. (2014), but other important lipids were also 
present.  
The health promoting potential of GS-CL has been mainly attributed to phytosterols and 
policosanols, which are located in the oil and wax fraction, respectively (Althwab, Carr, Weller, 
Dweikat, & Schlegel, 2015). In particular, evidence linking phytosterols to cholesterol lowering 
and anti-cancer benefits is increasing (Carr, Ash, & Brown, 2010) (Awad & Fink, 2000). 
Phytosterols present in the GS oil fraction exists as both free sterols and sterol esters (Singh, 
Moreau, & Hicks, 2003), with the predominant sterols being β-sitosterol, campesterol and 
stigmasterol (Leguizamón, Weller, Schlegel, & Carr, 2009). Phytosterol level ranges from 46 to 
51 mg/100 g (Singh, Moreau, & Hicks, 2003) but varies depending on extraction method and the 
physical state of the sorghum material (Leguizamón, Weller, Schlegel, & Carr, 2009).  
Policosanols have also been reported to improve blood lipid profile (Gouni-Berthold & 
Berthold, 2002) albeit other reports have disputed these claims (Lin, et al., 2004) (Dulin, Hatcher, 
Sasser, & Barringer, 2006) (Murphy, Saint, & Howe, 2008). These compounds account for 37-
44% of the GS wax fraction (Hwang, Weller, Cuppett, & Hanna, 2004) with the major 
policosanols consisting of octacosanol (28:0) and triacontanol (30:0) followed by hexacosanol 
(26:0) and dotriacontanol (32:0) (Leguizamón, Weller, Schlegel, & Carr, 2009). Similar to the  
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Figure 1 TLC analysis of white GS-CL (Carr, et al., 2005). TLC plate was developed in a solvent 
system of hexane: diethyl ether: acetic acid (85:15:2, by volume). 
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Figure 2 Illustration of lipid profile of white GS-CL (Carr, et al., 2005). 
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whole kernel phytosterols, the policosanol composition and quantity can differ due to the 
extraction method used, the physical form of GS (Leguizamón, Weller, Schlegel, & Carr, 2009) 
and the type of GS as established in this study.  
i. Atherosclerosis 
Carr et al. (2010) reviewed the positive impact of cholesterol lowering effect of 
phytosterols when consumed for therapeutical purposes, especially in terms of low density 
lipoprotein (LDL) cholesterol. Several researchers proposed that sorghum lipid extracts will 
improve plasma and liver lipid profile due to its high phytosterol content. To test this hypothesis, 
hamsters were fed a GS-CL supplemented (0.5, 1 and 5% w/w) fatty diet that was able to elevate 
both plasma and liver low density lipoprotein (LDL) cholesterol (Carr, et al., 2005). Plasma non-
high density lipoprotein (HDL) levels decreased significantly when the animals were fed the 1 
and 5% supplement, resulting in a reduction of 40 and 65%, respectively, compared to the 
animals fed the HF diet only. Plasma HDL cholesterol of the supplemented groups trended 
upward with the GS-CL supplements although not significantly. In addition, cholesterol 
absorption efficiencies of the hamsters consuming the 0.5, 1, and 5% GS-CL supplemented diets 
were reduced by 62.5%, 59.7% and 56.6%, respectively, compared to 67.2% presented by the HF 
group. The cholesterol lowering effect of GS-CL was thus attributed in part to the  inhibition 
cholesterol absorption. Using the animal pellets from the above described project, Martínez et al. 
(2009) showed that the gut microbiota was altered and concluded that the cholesterol lowering 
effect of GS-CL could also be partially attributed to this effect.  
On the other hand, Hoi et al. (2009) showed that GS dry distiller grain with soluble 
(DDGS) lipid fraction included into a HF diet also resulted in increased cholesterol excretion in a 
dose-dependent manner (0, 0.5, 1 and 5% of GS-DDGS), which correlated to decreased liver 
cholesterol concentration. Although plasma HDL levels were not affected by any of the doses, 
non-HDL did decrease but only for the 5% supplemented fatty diet (by 69%). 
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Lee et al. (2014) fractionated GS lipid obtained from whole kernel of white GS to the oil 
and wax extracts and showed that the phytosterols and policosanols remain in the oil fraction and 
in the wax fraction, respectively. Again using hamsters as the animal model, the oil supplemented 
(5%, w/w) into a fatty diet resulted in significantly lower non-HDL plasma (25% reduction) and 
liver esterified cholesterol (64% reduction). Alternatively, the wax supplement (5%, w/w) did not 
affect either plasma or liver cholesterol, but did increase excreted neutral sterols and bile acids. 
The researchers hypothesized that synergistic effects between oil and wax may be involved in the 
anti-atherosclerosis effect of as the GS-CL (Carr, et al., 2005) exerted greater benefits when 
compared to either the oil-wax fractionated results (Lee, et al., 2014). It must be noted however 
that the former study used diets that contained lower fat levels than the latter study. Still, the lipid 
fraction from the GS-DDGS (Hoi, et al., 2009) used a HF diet similar to that used in the original 
GS-CL study (Carr, et al., 2005), but the cholesterol lowering effects were much less. As such, 
synergism between the two fractions may play an important role in the protective properties of 
GS-CL.  
The GS-CL could also exert its cholesterol lowering effect through the regulation of 
hepatic cholesterol metabolism, particularly effecting 3-hydroxy-3-methyl-glutaryl-coenzyme A 
(HMG-CoA) reductase, sterol regulatory element-binding protein (SREBP)-2 and fatty acid 
synthase. Kim, Kim & Park (2015) showed that all of these proteins were significantly 
downregulated whereas AMPK phosphorylation was considerably upregulated in 
hypercholesterolemia mice fed a GS supplement. 
ii. Gastrointestinal regulation 
Cholesterol homeostasis improvements in response to GS-CL consumption has been 
strongly associated with changes in gut microbiota based on a study of the gut microbiome of 
hamsters consuming GS-CL (Martínez, et al., 2009). As previously described, the study indicated 
that the regulating effects of GS-CL on hamster lipid profile, at least in part, act through the gut 
microbiota. These conclusions were based on the data showing a strong correlation between HDL 
10 
 
 
 
cholesterol levels and an increase in Bifidobacteria whereas a decrease in Coriobacteriaceae was 
significantly associated with non-HDL cholesterol (Martínez, et al., 2009). The hypothesis that 
dysregulated lipid profile could be attributed by the dysfunction of a single or several species of 
gut microbiota was thus proposed. To test this hypothesis, systematic gut microbiome sequencing 
and wide sampling from dyslipidemia population were needed. Therefore, in a latter study, 
Martínez et al. (2013) used plant sterol esters (PSE) to mimic phytosterols present in GS-CL. The 
results showed a prominent correlation between two species, Coriobacteriaceae and 
Erysipelotrichaceae, and the host fecal and biliary cholesterol excretion, which fit a bacterial 
inhibition model perfectly. The researchers further proposed that host cholesterol excretion 
modulated the microbiota through the antibacterial action of cholesterol, whereas PSE did not 
possess the inhibitory effect, which accounts for the different microbial composition between the 
groups (Martínez, et al., 2013).  
II. Nutrient overload induces metabolic and energy switch 
Exposure to excess nutrients and thereby energy is a modern phenomenon that has been 
caused by changes in dietary patterns and lifestyles. Although temporary nutrient excess can be 
accommodated and remediated by the inherent protective responses, chronic and persistent 
nutrient overload irreversibly disturbs metabolic homeostasis, leading to the gradual development 
of obesity (Zhang, et al., 2008). Indeed obesity has been linked to an array of metabolic disorders, 
including insulin resistance and type II diabetes (Lionetti, et al., 2009), cardiovascular diseases  
(Jia, Aroor, Martinez-Lemus, & Sowers, 2014) and even cancer (Taubes, 2012). The prevalence 
of obesity and its associated medical disorders has increased dramatically in the U.S. and 
throughout much of the world in the past decade (Jia, Aroor, Martinez-Lemus, & Sowers, 2014).  
A. HF diets cause perturbations in energy metabolism 
Of particular interest for our study, HF high cholesterol western diets induce prominent 
changes in energy metabolism. In order to cope with HF high cholesterol and low glucose, cells 
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switch to fatty acid β oxidation as the main energy source (Jiang , et al., 2013). Multiple 
researchers have conducted studies using HF high cholesterol fed animal models to understand 
the impacts of such a diet on human health. Zha et al. (2009) determined that a HF diet induces 
significant elevations in plasma fatty acids in a hamster model, whereas Boulangé et al. (2013) 
reported increased urine excretion of β oxidation intermediates in mice. Histopathological 
assessment also revealed excessive organ lipid accumulation (Jiang , et al., 2013) (An, et al., 
2013). Examination of the urine showed higher circulating fatty acids and their metabolites 
indicating the upregulation in fatty acid breakdown through β oxidation. These results also imply 
fatty acid overflow through the mitochondria (Boulangé, et al., 2013). Excessive acetyl-CoA from 
mitochondrial fatty acid oxidation may then be stored by accumulating around and entering key 
organs, which has the potential of saturating the TCA cycle causing mitochondrial stress 
(Boulangé, et al., 2013). Furthermore, Boulangé et al. (2013) showed that tricarboxylic acid 
(TCA) cycle intermediates from succinyl-CoA to oxaloacetate (OAA) are significantly elevated 
in the urine of HF fed mice. An et al. (2013) also determined that HF intervention increases the 
levels of succinate and fumarate in rat liver. Chronic fatty acid overload in mitochondria leads to 
mitochondria overwork and impairment and, in turn, damaged energy metabolism.  
As the intake of a HF western diet progresses, low glucose supply becomes more evident. 
Zha et al. (2009) and Guo et al. (2016) reported a reduction in plasma glucose level in a hamster 
model 12 to 24 weeks into HF feeding. Moreover, An (2013) showed a reduction in liver glucose 
and glycogen levels in a rat model. At the same time, circulating and liver alanine and lactate 
trended upward due to HF diet and low glucose supply to the muscles (An, et al., 2013). These 
results are most likely due to the lack of glucose as primary energy source, which is essential 
nutrient for many tissues that include central nerve system and red blood cells. The depletion of 
glucose thereby triggers the activation of several pathways employing non-carbohydrate substrate 
to synthesis glucose (Boulangé, et al., 2013).  
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Amino acid catabolism is significantly upregulated in animal models fed HF diets in an 
effort to generate more glucose. For example, levels of many amino acids, including methionine, 
phenylalanine, tyrosine, proline, tryptophan, glutamine, valine, lysine, glycine and histidine were 
reduced in the plasma of HF high cholesterol fed hamsters (Zha, et al., 2009) and HF fed rats (An, 
et al., 2013). Boulangé et al. (2013) also measured significant elevations of branched chain amino 
acid (BCAA) catabolic intermediates in urine excreted by HF fed mice, including leucine, 
isoleucine and valine intermediates. Coupled with higher levels of TCA intermediates from 
succinyl-CoA to OAA, the researchers concluded that the upregulated BCAA catabolism feeds 
into the TCA cycle as an anaplerosis source in order to produce glucose through gluconeogenesis 
(Boulangé, et al., 2013). An et al. (2013) also supported this conclusion with an exception that the 
HF diet group presented with significant reductions in urinary excretion of TCA intermediates 
including citrate, α-ketoglutarate (α-KG), succinate and fumarate. Additionally, Kowalski et al. 
(2015) performed an oral C13 glucose tolerance test on mice fed with a HF diet for 10 weeks. 
Compared to control mice (no fat included in the diet), the muscles of the HF diet mice resulted 
in a reduction of the C13 label for all the TCA cycle intermediates with the notable exception of 
citrate. These results were attributed to a gradual carbon dilution that were contributed by the 
alternative unlabeled carbon source entering the TCA cycle through multiple anaplerosis process, 
such as glutaminolysis and other amino acid catabolism. 
As HF diet consumption proceeded to 42 weeks, circulating glucose and hepatic glucose 
and glycogen levels were restored via gluconeogenesis from amino acids and other non-
carbohydrate substrates (Jiang , et al., 2013). Concurrently, urinary, hepatic and plasma alanine 
and lactate levels were reduced as reported by Guo et al. (2016) and Jiang et al. (2013). However, 
elevated glucose level remained in circulation without being taken up by cells due to a persistence 
HF intake fulfilling the role as main energy source. Ultimately, a HF diet could initiate many 
metabolic disorders, such as obesity, type II diabetes and atherosclerosis (Hotamisligil & Erbay, 
2008) by initially eliciting stress responses.  
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B. HF diets initiate intestinal stress via various mechanisms 
Epidemiological studies have shown that a HF western style diet increases the risk of 
inflammatory bowel diseases (Teixeira, et al., 2011) (Kim, Gu, Lee, Joh, & Kim, 2012). As 
reported by Kim et al. (2010), a HF diet increased the susceptibility of mice to DSS-induced 
inflammation and exacerbated the severity of DSS-induced colitis. Increased macrophage not 
only infiltrated the sub-epithelial region of lamina propria but also at the base of crypts and in the 
sub-mucosal layer (Erdelyi, et al., 2009) (Cheng, et al., 2016) (Kim, et al., 2010). Moreover, the 
HF diet induced the expression of the pro-inflammatory cytokines (TNF-, IL-1, and IL-6) and 
the activated pro-inflammatory enzymes and proteins such as NF-B, iNOS, myeloperoxidase 
(MPO) and monocyte chemoattractant protein (MCP)-1 (Kim, Gu, Lee, Joh, & Kim, 2012) 
(Bastie, et al., 2012).  
Kim et al. (2012) showed that mice fed a HF diet exhibited higher endotoxin levels in 
both plasma and fecal samples, indicating the progression of localized intestinal inflammation to 
systemic inflammation. High circulating endotoxin levels also indicate increased intestinal 
permeability. This research was supported by Murakami et al. (2016) and Kim et al. (2012) who 
both showed reduced expression of tight junction proteins, markers for intestinal 
hyperpermeability in the colon of mice fed a HF diet (Murakami, Tanabe, & Suzuki, 2016). 
Intestinal permeability has been associated with gut microbiota dysregulation. For example, Kim 
et al. (2012) showed that HF diet dysregulates gut microbiota by increasing the ratio between 
Firmicutes and Bacteriodetes, and also induces the growth of Enterobacteriaceae in a mice 
model. Shen et al. (2014) also reported that mice fed with HF diet have greater abundance of 3 
types of sulfidogenic bacteria in colonic mucosa, resulting in the production of the pro-
inflammatory compound, hydrogen sulfide (Carbonero, Benefiel, Alizadeh-Ghamsari, & Gaskins, 
2012). 
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In addition to local and systemic inflammation, Erdelyi et al. (2009) demonstrated that 
the HF diet induces oxidative stress in colon, as genes involved in oxidative stress responses were 
unregulated, including Nrf2, a redox sensitive transcription factor. Moreover, metabolic profiling 
of colonic redox active compounds showed that HF feeding significantly reduces cysteine: 
cystine ratio, providing further proof of colonic oxidative stress (Erdelyi, et al., 2009), which if 
left unchecked can lead to chronic inflammation and associated diseases.  
III. Metabolomics research on bioactive food ingredients  
A. Metabolomics  
By definition, the metabolome is a “snapshot” of the entire complement of metabolites 
produced at any given point in time by a biological system. It is therefore the goal of 
metabolomics to describe, both qualitatively and quantitatively, the metabolome. Metabolomics 
can thus monitor changes of the complete set of metabolites in and derived from an organism, the 
end products of gene expression and/or in response to environmental changes (van der Werf & 
Venema, 2001). Metabolomics is the most recent addition to the applied genomics technologies, 
or the ‘omics’, that include genomics, transcriptomics and proteomics. Although the least well 
defined of the ‘omics’ technology, metabolomics provides multiple attributes in terms of 
understanding a complex system. Firstly, the number of metabolites (~2,500) is more than an 
order of magnitude lower than the 30,000 to 40,000 genes in the human genome, making it a 
simpler screening tool (Kell, 2006). Secondly, as metabolic pathways between species and 
organisms are highly conserved (Nikolaev, Burgard, & Maranas, 2005) (Ravasz, Somera, 
Mongru, Oltvai, & Barabási, 2002), metabolomics allows the use of biological models to reflect 
biochemical changes in response to external stimuli (Weljie, Dowlatabadi, Miller, Vogel, & Jirik, 
2007). And thirdly, as the final downstream outcome of the genome, transcriptome and proteome, 
the metabolome reflects phenotype or function (Weljie, Dowlatabadi, Miller, Vogel, & Jirik, 
2007).  In other words, if the blueprint of any biological system is represented by the genome, 
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then its function is expressed by its metabolome. Therefore, metabolomics is able to provide a 
metabolic snapshot of an organism by bridging the genotype to phenotype gap.  
The main challenges of metabolomic based research are the heterogeneity of the 
molecules, low dynamic range of analytical techniques, limited through-put of the instruments 
and the lack of validated extraction protocols. To date, it is impossible to analyze multiple classes 
of metabolites with a single analytical method. Selection of appropriate metabolomic analytical 
techniques is usually a compromise between high-throughput, selectivity and sensitivity 
requirements. To achieve a comprehensive and accurate understanding of a metabolome, at least 
two or more analytical techniques are needed. The most commonly employed analytical methods 
include gas chromatography (GS), high performance liquid chromatography (HPLC), capillary 
electrophoresis (CE), nuclear magnetic resonance (NMR), and mass spectrometry (MS) (Gries, 
2008). 
Two approaches are typically cited to conduct a metabolomics study, i.e., metabolic 
profiling and metabolic fingerprinting, which simplifies the study of the metabolome. Metabolic 
profiling refers to the analysis of a set of preselected metabolites with the goal of identifying and 
quantitating each metabolite. However, this strategy limits the detection to molecules with 
specific characteristics, such as similar chemistries (organic acids versus amino acids,) pathways 
of origin (tricarboxylic acid vs eicosanoid pathway), biological relevance (specific metabolic 
biomarkers) and / or physiological interactions (Dettmer & Hammock, 2004). As such metabolic 
profiling provides precise and accurate changes to a wide array of key metabolites in response to 
various genetic or environmental stimuli. When key metabolites can be analyzed simultaneously, 
metabolic profiling can be equally or even more powerful as a global metabolomics, or metabolic 
fingerprinting. The latter approach does not identify specific metabolites but rather compares 
changes in patterns of metabolic responses to environmental stimulations or genetic perturbations 
(Dettmer & Hammock, 2004). The entire data set or sub-set can then be analyzed by pattern 
recognition and related multivariate statistical approaches to determine if the responses are 
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significant between samples. Depending on the objective of a study, researchers are currently 
applying one or both approaches (Lee, 2013). 
B. Metabolomics as a tool to study the effects of dietary bioactive agents 
  Metabolomics has been employed to investigate the health benefits of bioactive food 
ingredients although these studies remain limited. Nevertheless, Zhou et al. (2015) applied 
metabolic profiling on the urine of a hyperlipidemia rat model by using ultra-performance liquid 
chromatography (UPLC) coupled with electrospray ionization quadruple time-of-flight mass 
spectrometry (ESI-QTOF-MS) to investigate the regulatory effect of mangiferin. The ensuing 
data were then analyzed with principle component analysis (PCA) and orthogonal partial least-
squares discriminant analysis (OPLS-DA) to visualize the metabolic trajectory as a means to 
discover potential biomarkers affected by a HF diet and mangiferin administration (Zhou, et al., 
2015). Li et al. (2015) employed proton nuclear magnetic resonance (1H NMR) coupled with 
mass spectrometry to conduct metabolomic profiling on the urine of hyperlipidemia mice fed a 
diet supplemented with curcumin. By combining the ‘omics’ with statistical analysis to study 
nutraceutical intervention, the researchers were able to identify more natural substances that may 
have medical values. Such applications provided the foundation for this research.  
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2. Objective and specific aims  
The health promoting properties of most dietary components have been primarily studied 
using isolated components despite emerging but limited research showing that whole food or 
complex rich extracts impart greater health benefits than the sum of the individual components 
(Junio, et al., 2011). Moreover, the metabolic mechanisms that recognize and respond to such 
molecules and thereby promote a healthy state remain largely unknown. The objective of this 
project was to determine the ability of GS-CL (rich in both health benefiting phytosterols and 
policosanols) to protect energy pathways and the short chain fatty acid (SCFA) profile produced 
by gut microbiome thus mitigate intestinal stress caused by a HF diet, which if left unchecked can 
lead to hypoxia or inflammation, that in turn can progress into other chronic conditions. 
Considering that the surface of GS contains a complex matrix of lipids, including phenols for 
tannin containing sorghums, the central hypothesis for this project is that this richly diverse 
extract is able to protect the following pathways, glycolysis, TCA, pentose phosphate pathway 
(PPP), and amino acids (i.e., the precursors of many energy metabolites) against modulation 
caused by a HF diet. Moreover, the GS-CL is expected to prevent the HF diet from interfere the 
production of SCFA produced by the gut microbiome. This hypothesis was tested by completing 
the following specific aims.   
Specific Aim 1: To determine the ability of different dosages of red GS-CL (1,3 and 5%) 
to prevent intestinal stress caused by a HF diet by monitoring key energy pathways 
(carbohydrate, amino acid and nucleotide metabolism) by using a hamster model and metabolic 
profiling approaches. The working hypothesis for this aim is that the red GS-CL will provide a 
protective response against HF induced energy modulation in intestine but the degree will be 
dependent on GS-CL dosages.    
Specific Aim 2: To determine the ability of different dosages of red GS-CL (1,3 and 5%) 
to prevent the impact of HF diet on the production and profile of SCFA in large intestine. The 
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working hypothesis for this aim is that the red GS-CL will provide a protective response against 
the inhibitory effect of HF diet on SCFA profile produced by the gut microbiome.  
Specific Aim 3: To characterize red GS-CL in terms of its chemical compositions. The 
accessed need for this aim is that such information was required to ultimately determine the 
components responsible for protecting against intestinal stress.  
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3. Material and methods 
I. Specific Aim 1 and 2: Metabolic actions of fatty diet without and with 
different doses (1, 3, 5%) red grain sorghum crude lipid on key energy 
pathways and SCFA profile 
A. Grain sorghum crude lipid extraction 
The GS-CL was prepared with food grade dark red high tannin GS whole kernel (a 
germplasm line from the Texas AES-USDA sorghum conversion program) provided by Dr. 
Ismail Dweikat (University of Nebraska-Lincoln) and Nu Life Market, Kansas, grown and 
harvested in 2014. The GS-CL was extracted from the surface  of red GS by refluxing, previously 
described by Leguizamón et al. (2009). Briefly, whole kernel red GS (1 kg) was refluxed with 
hexane (1 L) for 30 min at a temperature slightly below 60 °C in a three-neck round bottom flask 
connected to a condenser. The mixture was cooled to room temperature and then passed through 
two layers of coffee filter and a Whatman No. 2 filter under vacuum. The solvent was evaporated 
from the GS extract using a rotavapor. The residue GS-CL was collected and stored at -18°C until 
use.  
B. Diet and animal care 
Five different diets were prepared based on the AIN-93M purified diet, which consisted 
of a negative control (low fat), an high fat (HF) positive diet and three HF diets supplemented 
with either 1.0, 3.0, and 5.0% (w/w) GS-CL (Table 1). For the HF diets, coconut oil, cholesterol 
and GS-CL supplements were added at the expense of cornstarch.  
Fifty five male Syrian hamsters (Charles River, Wilmington, MA), age 9 weeks with 
body weight ranging from 110 to 120 g, were used for this study. The hamsters were randomly 
assigned to the five experimental diets (n=11) to ensure a similar average weight among the 
groups. Each hamster was housed individually in polycarbonate cage with wood chip bedding in 
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a controlled environment of 25 °C with a 12 h light-dark cycle, and had free access to water and 
food. The animals were maintained on their assigned diet for 4 weeks, and their food intake was 
recorded on a weekly basis.  The bedding was also changed weekly, whereas the body weight of 
each hamster was measured at baseline and at the end of the study. Food was removed 14 h 
before CO2 asphyxiation to achieve overnight fasting.  The large intestine was collected, 
immediately frozen with dry ice and stored at -80 °C until analyzed. All experimental procedures 
were approved by the Institutional Animal Care and Use Committee at the University of 
Nebraska.   
C. Extraction of targeted metabolites 
Metabolite extraction was initiated by grinding the frozen large intestinal tissue in dry ice 
until a fine powder was produced. Approximately 120 mg of the ground tissue was weighed in a 1 
mL glass homogenizer followed by the addition of 1 mL ice-cold nanopure water. The tissue was 
then homogenized while maintained in flaked ice until no large tissue pieces were visible. The 
homogenate was then centrifuged with a Beckman GS-6R centrifuge at 4°C for 30 min, which 
completed pelleted the solid material. The supernatant was collected and passed through a EMD 
Millipore Amicon centrifugal filter unit 10 KDa to achieve a clear, protein-free metabolite 
extract. The extract was concentrated with a Labconco CentriVap concentrator to a total volume 
of approximately 100 µL (Figure 3).  
D. Analysis of tissue extracts 
The eight glycolysis intermediates and two pentose phosphate pathway intermediates 
were analyzed using a LC-ESI-MRM-MS. Samples were evaporated to dryness using a Speed-
vac concentrator (Thermo Savant Instruments, USA) at 4 °C.  The pellets were re-dissolved in 50 
µL of nanopure water and vialed prior to injection on the LC system. The HPLC (Agilent 1200 
series, Santa Clara, CA) separation was achieved using an XBridge Amide column (2.1 × 100 
mm, 3.5 µm) ( Waters Millipore, Milford, MA). The mobile phase consisted of 20 mM   
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Table 1 Composition of five hamster diets. 
Food Component* Control HF1 
HF + 1% 
GS-CL2 
HF + 3% 
GS-CL2 
HF + 5% 
GS-CL2 
Cornstarch 455.7 353.7 343.7 323.7 303.7 
Dextrinized cornstarch 155.0 155.0 155.0 155.0 155.0 
Casein 140.0 140.0 140.0 140.0 140.0 
Sucrose 100.0 100.0 100.0 100.0 100.0 
Coconut oil --- 100.0 100.0 100.0 100.0 
Soybean oil 50.0 50.0 50.0 50.0 
50.0 
Insoluble fiber 
(cellulose)  
40.0 40.0 40.0 40.0 40.0 
Soluble fiber  
(guar gum) 
10.0 10.0 10.0 10.0 10.0 
GS-CL --- --- 10.0 30.0 50.0 
Cholesterol --- 2 2 2 2 
AIN-93 mineral mix 35.0 35.0 35.0 35.0 35.0 
AIN-93 vitamin mix 10.0 10.0 10.0 10.0 10.0 
L-Cysteine 1.8 1.8 1.8 1.8 1.8 
Choline bitartrate 2.5 2.5 2.5 2.5 2.5 
* Dyets, Inc. Bethlehem, PA; 
1HF diet contained extra coconut oil and cholesterol at concentrations of 10% and 0.2%, respectively, at the expense of cornstarch; 
2GS-CL were added at 1.0, 3.0 and 5.0% at the expense of cornstarch.  
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Figure 3 The extraction of tissue metabolites. 
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ammonium hydroxide and 20 mM ammonium acetate in nanopure water (A) and LC-Grade 
Acetonitrile (B). The gradient began at 5% A and 95% B for 3 min, then to 95% B over 10 
column volumes, 95% B over 5 column volumes and finally 5% A over 10 column volumes; all 
steps at a flow rate of 0.5 mL/min. The eluent of the column was fed into the electrospray ion 
(ESI) ion source operating in negative ionization mode at a voltage of -4500 V, at a temperature 
of 500 °C and with source gasses at 60 L/min (GS1 and GS2). Multiple reaction monitoring 
(MRM) was employed for metabolite detection and quantification on a Sciex 4000QTrap 
(Framingham, MA). A single precursor and single fragment m/z values were paired for the 
detection of each metabolite. External standards at 10 ug/mL were used for calibration (Sigma-
Aldrich, St.Louis, MO). All data was normalized according to tissue weight, and each metabolite 
was expressed as mean +/- standard error of the mean (µg/g) of eleven biological replica.  
Amino acids were analyzed using EZ: faastTM amino acid analysis kit (Phenomenex Ltd. 
Germany) as per manufacturer’s instructions. This analysis consisted of a solid phase extraction 
step followed by a derivatization and a liquid/liquid extraction, and the derivatized samples were 
quickly analyzed by gas chromatography with FID detection. More specifically, the solid phase 
extraction was performed via a sorbent packed tip that binds amino acids while allowing 
interfering compounds to pass through the column. The amino acids bound to the sorbent were 
then released with sodium hydroxide, 3-picoline and N-propanol. The sample mixture was 
allowed to incubate at room temperature during derivatization, which was accomplished with the 
above mentioned reagent. After a clear separation occurred between the organic and aqueous 
phases, the upper organic phase containing the derivatized amino acids was collected and 
analyzed on an Agilent 7820A GC instrument with a flame ionization detector (FID) detector. 
The amino acids present in the extracts were resolved, identified and quantified with a 10m × 
0.25mm ZebronTM EZ-AAA amino acid GC column under the following conditions: initial oven 
temperature 110 °C, rising to 320 °C at 32 °C/min with the injector temperature set at 250 °C. 
The carrier gas was helium adjusted to a split ratio of 15:1. Each amino acid was quantified 
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against an internal standard (Norvaline). All data was normalized according to tissue weight and 
each amino acid was expressed as mean +/- standard error of the mean (µg/g) of eleven biological 
replica.  
The remaining metabolites listed (Table 2) were analyzed with Beckman P/ACE MDQ 
capillary electrophoresis system (Beckman Coulter, USA) interfaced to a 67 cm long Agilent bare 
fused silica capillary (i.d. 50 µm) and a 200 nm UV filter. A 250mM sodium phosphate buffer 
(pH 6.0) containing 0.1 mM hexadecyltrimethylammonium bromide (CTAB) and 5% methanol 
served as background electrolytes (BGE) and the samples were injected onto the capillary using a 
pressure of o.5 psi for 5 sec, and the metabolites were separated at 25 °C and 10 KV. For all the 
CE assays, the capillary was preconditioned regeneration solution (0.1 N NaOH, Beckman 
Coulter, USA) for 2 min and running buffer for 2 min. After each run, the capillary was cleaned 
by rinsing with 1 M HCl for 2 min, capillary regeneration solution for 5 min and nanopure water 
for 2 min. All solutions and samples were filtered by a  0.45 µm filter unit before injected to the 
capillary. Standard curves for each metabolite were constructed with a cocktail containing 
external standards. The sample analyte peaks were identified by both retention time and standard 
spikes. System control, data acquisition, and data analysis were performed with a Beckman 32 
Karat workstation. All data was normalized according to tissue weight and each metabolite was 
expressed as mean +/- standard error of the mean (µmol/g) of eleven biological replica.  
II. Specific Aim 3:  Characterization of grain sorghum (sorghum bicolor) 
crude lipid 
The simple lipid profile was acquired using thin layer chromatography (TLC), as 
described by White et al. (1998). A cocktail of standards containing monoacylglycerols, 1,2-
diacylglycerols, 1,3-diacylglycerols, triacylglycerols, fatty acid methyl esters, D-α-tocopherol 
acetate, three polyoxyethlenesorbitan monooleate and octacosanol was prepared. Approximately   
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Table 2 Metabolites of targeted metabolomic profiling. 
 Metabolites  Analytical method  
Glycolysis 
Glucose-1-phosphate MS 
Glucose-6-phosphate MS 
Fructose-6-phosphate MS 
Fructose-1,6-phosphate MS 
Dihydroxyacetone phosphate MS 
Glyceraldehyde-3-phosphate MS 
Glycerol-3-phosphate MS 
Glycerate-3-phosphate MS 
Phosphenolpyruvate CE 
Pyruvate CE 
Pentose phosphate pathway 
Ribose-5-phosphate MS 
Ribose MS 
TCA cycle 
Acetyl-CoA CE 
Citrate CE 
α-ketoglutarate CE 
Succinate CE 
Malate3 CE 
Fumarate CE 
Coenzymes 
NAD+ CE 
NADH CE 
NADP+ CE 
NADPH CE 
GSH CE 
GSSG4 CE 
Organic acids 
Oxalate2 CE 
Formate CE 
Malonate1 CE 
Acetate CE 
Propionate CE 
Butyrate1 CE 
Lactate1 CE 
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Amino acids 
Alanine GC 
Sarcrosine GC 
Glycine GC 
α-aminobutyric GC 
Valine GC 
Leucine GC 
Isoleucine GC 
Threonine GC 
Serine GC 
Proline GC 
Asparagine GC 
Aspartic acid GC 
Methionine GC 
Hydroxyproline GC 
Glutamic acid GC 
Phenylalanine GC 
Glutamine GC 
Ornithine GC 
Lysine GC 
Histidine  GC 
Tyrosine GC 
Tryptophan GC 
Cysteine  GC 
Nucleotides 
ATP CE 
ADP CE 
AMP CE 
GTP CE 
GDP CE 
GMP CE 
All amino acid standards come from EZ: faastTM kit, the rest of standards were purchased from Sigma-Aldrich, except for the 
following: 
1 Standard purchased from Alfa Aesar;  
2 Standard purchased from Fisher chemical;  
3 Standard purchased from MP Biomedicals, LLC; 
4 Standard purchased from Fluka.  
  
27 
 
 
 
25 mg of the extracted GS-CL was suspended in 1 mL of chloroform to a final concentration of 
20 mg/mL. The GS-CL was completely dissolved by heating to 60°C. The sample and standard 
was spotted on a 10 × 20 cm silica gel 60 plate using 10 µL aliquots. The plate was then placed in 
a resolving chamber containing hexane, diethyl ether and acetic acid (85:15:2, by volume) until 
the solvent had eluted near the top of the plate. The plate was removed and submerged briefly in 
10% cupric sulfate, 8% phosphoric acid solution and air-dried in a chemical fume hood. Bands 
were visualized by charring the dried plate in an oven adjusted to165 °C for 10 min.  
The GS-CL fatty acid profile was analyzed with a Agilent 7820A gas chromatograph 
(GC) system interfaced to a FID, and the resolution method used was based on the procedure 
previously described by Metcalfe et al. (1966). Briefly, a sample of GS-CL (0.05 g) was 
derivatized to volatile fatty acid methyl esters (FAMEs) by mixing with 2 mL of 14% boron 
trifluoride in methanol and heating at 100 °C for 5 min. After cooling to room temperature, the 
FAME were extracted with 1:2 hexane and water (v/v) by centrifugation until a well-defined 
pellet had formed. The FAMEs-containing hexane layer was analyzed using a GC DB-Wax 
column (30 m × 0.25 mm, J&W Scientific) under the following conditions: initial oven 
temperature was 185 °C for 12 min, increased to 210 °C at 10 °C /min, held for 1 min using a 
FID temperature of 250 °C. Helium served as the carrier, which was set at a split ratio of 10:1. 
Fatty acid levels were reported as relative percent of 100% crude lipid.  
Quantification of phytosterols and policosanols present in the GS-CL was achieved by 
GC (Agilent 7820A GC system) interfaced to a FID. Based on the procedure described by 
Leguizamón et al. (2009), a GS-CL sample (0.02 g) was mixed with the internal standards, 0.1 
mg 5α-cholestane and 0.1 mg policosanol heptacosanol (C27). The mixture was saponified with 1 
M methanolic potassium hydroxide at 50 °C for 1 h with occasional agitation. Non-saponifiable 
lipids were separated by adding 1 mL of deionized water and 3 mL of hexane to the mixture. The 
hexane phase was separated by centrifuging at 3000×g for 5 min and evaporated under nitrogen at 
50 °C. The dried lipids were derivatized by reacting  with 100 µL pyridine for 30 min followed 
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by the addition of 50 µL Sylon BTZ (Supelco, Bellefonte, PA, USA) at room temperature. Each 
sample was analyzed with a 0.32 mm × 30 m DB-5 capillary column (J&W Scientific, Folsom, 
CA, USA) under the following conditions: initial oven temperature was 100 °C, rising to 300 °C 
at 5 °C/min with the injector and FID temperature set at 270 °C and 300 °C, respectively. Helium 
served as the carrier, which was adjusted to a split ratio of 50:1. External phytosterols were used 
to identify and quantitate the individual phytosterols that included stigmasterol, sito-sterol and 
campesterol. Each type of policosanol and sterol were expressed as the mean +/- standard 
deviation (µg/g of lipid extract) of triplicate analyses.  
Tocopherols present in the GS-CL extract were determined following a colorimetric 
method described by Wong, Timms and Goh (1988) with minor modification. A sample (200 mg) 
was weighed into a 10 mL volumetric flask and 5 mL hexane: isopropanol (3:2, v/v) was then 
added. The GS-CL was allowed to dissolve in this solvent by occasionally agitating the sample at 
room temperature followed by adding 3 mL of 0.07% 2,2’-bipyridine in 95% ethanol and 0.5 mL 
0.2% ferric chloride in 95% ethanol sequentially. The sample was bought to a final volume of 10 
mL with 95% ethanol, and absorption was measured with a Beckman Coulter DU800 
spectrophotometer at 520 nm. An external calibration curves was constructed using the same 
method but employing the standard, α-tocopherol. Tocopherol levels in the sample were 
calculated as the mean +/- standard deviation mg equivalents of α-tocopherol per g of crude lipid 
of triplicate analyses.  
Carotenoid levels were determined following a colorimetric method described by 
Lichtenthaler and Buschmann (2001). A sample of GS-CL(200 mg) was weighed into a screw 
cap tube followed by the addition of 1.6 mL methanol: water (94:6, v/v). The mixture was 
sonicated for 30 min in 45-50 °C water bath, and then centrifuged for approximately 5 min to 
collect a clear supernatant. After previous steps were repeated two additional times 1.2 mL of 
methanol: water (94:6, v/v) were added to the sample to a final volume 6 mL. The solution was 
then centrifuged until clear supernatant was obtained, and the absorbance was measured with a 
29 
 
 
 
Beckman Coulter DU800 spectrophotometer at 470, 853 and 666 nm. The concentration of 
carotenoid was calculated as µg per g GS-CL by the following equations:  
𝐶ℎ𝑙𝑜𝑟𝑜𝑝ℎ𝑦𝑙𝑙 𝐴 (𝜇𝑔 𝑚𝑙⁄ ) = 15.65𝐴666 − 7.34𝐴653  
𝐶ℎ𝑙𝑜𝑟𝑜𝑝ℎ𝑦𝑙𝑙 𝐵 (𝜇𝑔 𝑚𝑙⁄ ) = 27.05𝐴653 − 11.21𝐴666  
𝐶𝑎𝑟𝑜𝑡𝑒𝑛𝑜𝑖𝑑𝑠 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝜇𝑔 𝑚𝑙⁄ ) = (1000𝐴470 − 2.86)×(𝑐ℎ𝑙𝑜𝑟𝑜𝑝ℎ𝑦𝑙𝑙 𝐴 − 129.2)×
𝑐ℎ𝑙𝑜𝑟𝑜𝑝ℎ𝑦𝑙𝑙 𝐵 245⁄ .  
This test was completed in triplicate and the carotenoid levels were expressed as the mean +/- 
standard deviation (µg/g of lipid extract).  
Lastly, tannin levels were determined by following a liquid-liquid extraction method 
described by Fuentes et al. (2012). A sample (2.5 g) of GS-CL was dissolved in 5 mL of hexane 
followed by the addition of 3 mL methanol:water (60:40, v/v). The mixture was centrifuged to 
achieve a clear phase separation. The methanol phase was collected, and the liquid/liquid 
extraction was repeated an additional time. The methanol phases from the two extractions were 
combined for tannin detection following a colorimetric method described by Bhat, Sridhar, and 
Tomita-Yokotani (2007). The methanol extract (1 mL) was combined with 5 mL of 4% vanillin 
in methanol and 8% HCL in methanol (1:1). After 20 min of incubation at room temperature, the 
absorbance was measured at 500 nm. Tannin levels were determined by constructing a calibration 
curve using catechin as an external standard. The tannin content was expressed as the mean +/- 
standard deviation of mg equivalents of catechin per g GS-CL of triplicate analysis.  
III. Statistical Analysis 
Univariate comparisons between control and HF groups were performed in R using non-
parametric Kruskal-Wallis test. Pairwise comparisons among the five treatment groups were 
performed in GraphPad Prism version 7 (GraphPad Software, La Jolla CA, USA) using one-way 
ANOVA followed by Tukey’s multiple comparison after confirming normal distribution in R. To 
compare metabolic changes among the groups, multivariate analysis was conducted, including 
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partial least squares-Discrimination analysis (PLS-DA) and orthogonal-PLS-DAs which were 
performed with MetaboAnalyst 3.0 (www.metaboanalyst.ca) and SIMCA-P+ 12.0 software 
(Umetrics; Sweden), respectively.   
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4. Results and discussion 
The health promoting properties of GS-CL reported to date has mainly focused on 
cholesterol management (Carr, et al., 2005) (Lee, et al., 2014) (Hoi, et al., 2009) with fewer 
reports on its role in modulating the intestinal microbiota (Martínez, et al., 2009) (Lee, 2013). 
Despite these established benefits, a critical gap in information remains on the impact of GS-CL 
on cells or tissues at the “omics” level, with an exception of a study performed by Lee (2013). In 
the latter research, metabolomic profiling was performed on both the liver and large intestine 
collected from hamsters fed HF diets supplemented with either 5% white GS oil or wax. The 
supplemented diets compensated for the changes caused by a HF diet to a large degree in large 
intestine, but the liver metabolome was affected only minimally (Lee, 2013). In the current study, 
metabolites of key energy pathways were profiled more extensively to achieve a comprehensive 
understanding of the mode of action behind this compensation in large intestine, and to determine 
if different lines of sorghum provided different benefits. Furthermore, the SCFA produced by the 
gut microbiome were also analyzed to determine whether the red GS-CL were able to mitigate the 
effects of HF on the microbiome. Lastly, the GS-CL was thoroughly characterized to provide 
information of the possible component(s) responsible for these effects.  
I. Animal body weight and food intake 
Baseline body weight of the hamsters were not significantly different among groups 
(117.13 ± 0.08 g). After the four week feeding study, each group gained weight (129.2 ± 2.7 g) 
with an average gain of 13.4 ± 2.1 g, which was not statistically different among the groups. In 
addition, food intake throughout the study remained constant for all groups (9.8 ± 0.5 g/day), 
showing that the supplemented diets were palatable.  
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II. Specific aim 1: Metabolic actions of HF diet without and with different 
doses (1, 3 and 5%) of red GS-CL on key energy pathways  
A. The effect of a HF diet on cellular central carbon metabolism 
i. Effect of HF diet on cellular energy production and redox balance 
Cellular energy status is reflected by the index “energy charge”, first defined by Atkinson 
and Walton (1967), which is shown below.  
𝐸𝑛𝑒𝑟𝑔𝑦 𝑐ℎ𝑎𝑟𝑔𝑒 =
[𝐴𝑇𝑃] + 12[𝐴𝐷𝑃]
[𝐴𝑇𝑃] + [𝐴𝐷𝑃] + [𝐴𝑀𝑃]
 
 When applied to the nucleotide data obtained from the intestinal analysis of both the control and 
HF groups, a significantly lower energy level (0.062 ± 0.004) was detected in the HF group than 
that of the control (0.297 ± 0.102) (Figure 4). These results thus confirm that a HF diet affects the 
ability of intestinal cells to generate energy, creating a hypoxic stress relative to a low fat diet.  
The HF diet consumed by the model system may have impaired their ability to generate 
energy by multiple mechanisms. First, the HF diet contained 10% more fat and less starch than 
that of the control diet (Table 1). Excessive fatty acids may have accumulated quickly in 
mitochondria for β oxidation, thereby over-stressing the organelle. This stress may have resulted 
in possible damages to the electron transport chain (ETC) (Boulangé, et al., 2013), and/or 
impairment to its ability to recycle NADH to NAD+. As is shown in Figure 5, the HF group 
presented with significantly lower NAD+ (4.05 ± 0.41nmol/g) when compared to control group 
(6.19 ± 0.65 nmol/g). The NAD/NADH ratio corresponding to the HF group (0.343 ± 0.029) was 
also much lower than that of the control group (0.488 ± 0.080). Similar to these results, several 
studies have shown that under excessive substrate availability, whether the substrate was glucose, 
lipid or amino acids, NAD+ decreased in skeletal muscle, liver and heart (Gumaa, McLean, & 
Greenbaum, 1971) (McGarry & Dobbins, 1999) (Vettor, et al., 1997). As the carrier of electrons 
generated from glycolysis and the TCA, the lower NAD+ and NAD/NADH ratio obtained from   
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Figure 4 Energy charge for control and HF groups. Values are shown as the means ± SEM, n=11. Statistical 
differences were evaluated using non-parametric Kruskal-Wallis test. 
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Figure 5 NAD+ and NAD/NADH ratio of control and HF groups. Values are shown as the means ± SEM, n=11. 
Statistical differences were evaluated using non-parametric Kruskal-Wallis test. 
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our studies denote a reduction in the ability of the intestinal cells to generate energy by disrupting 
cellular redox balance and causing oxidative stress  (Rosca, et al., 2012).  
This hypothesis was tested by monitoring glutathione in both its reduced (GSH) and 
oxidized forms (GSSG) as GSH is considered one of the most important free radical scavengers. 
The ratio of GSH/GSSG has thus been employed as a marker of cellular redox balance and 
oxidative stress (Zitka, et al., 2012). For the HF group, the GSH/GSSG ratio and GSH level were 
0.336 ± 0.026 and 0.015 ± 0.000 µMol/g respectively, trending lower than the 0.523 ± 0.108 and 
0.018 ± 0.002 µMol/g of the control group (Figure 6). Similarly, Ajiboye et al. (2016) also 
reported a decrease in GSH and GSH/GSSG ratio in the livers of HF fed rats.  
ii. Effect of HF diet on central carbon metabolism  
Glucose is the primary energy source for many organs, including the large intestine. 
Therefore, when fat is present in the diet at high levels, the cells are forced to use fatty acids as an 
energy income to accommodate the excessive fat and, at the same time, manage and/or 
compensate for the less-than-sufficient glucose (Boulangé, et al., 2013). Metabolite changes were 
thus investigated in large intestine by applying an OPLS-DA approach to compare animals fed a 
low fat control to those on a HF diet. As shown by OPLS-DA score plot (Figure 7A), the control 
clearly separated from the HF group. Based on the coefficient plot (Figure 7B), the levels of 
multiple metabolites in the HF group were elevated, including formate, fumarate, succinate, 
malate, PEP, acetate, AMP, GSSG. In contrast, decreased levels of oxalate, propionate, ATP, 
ADP, acetyl-CoA and most of the amino acids were also evident.  
Acetyl-CoA is considered a metabolic intersection due to its connection with many 
metabolic pathways, such as glycolysis and the TCA cycle, fatty acid and amino acid metabolism, 
protein acetylation and DNA methylation (Carrer, et al., 2017). The flux of this intermediate in 
and out of mitochondria thus represents the metabolic state of a cell as “fed” or “starved” (Shi & 
Tu, 2015). Under conditions of sufficient glucose or a “fed” state, acetyl-CoA from glycolysis 
fluxes out of the mitochondria for fatty acid synthesis and storage (Shi & Tu, 2015). However,   
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Figure 6 GSH/GSSG ratio and total glutathione in control and HF groups. Values are shown as the means ± SEM, 
n=11. Statistical differences were evaluated using non-parametric Kruskal-Wallis test. 
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under high fat and low carbohydrate conditions, a cell undergoes a pseudo starvation state by 
employing fatty acid β oxidation as a source for acetyl-CoA production. Most of the acetyl-CoA 
is maintained inside the mitochondria by inhibiting the activity of ATP citrate lyase (ACLY) 
(Carrer, et al., 2017), which catalyzes the conversion from acetyl-CoA to citrate. In the current 
experiment, the cellular net acetyl-CoA produced by the HF group was lower than that of the 
control group (p=0.112). Similarly, Carrer et al. (2017) reported a reduction of acetyl-CoA in a 
HF diet mice model. These results indicate that, as a source of acetyl-CoA, fatty acid is not as 
readily used and efficient as glucose, and the total generation of acetyl-CoA in a cell is slower 
when fatty acid is the major energy source (Fillmore, Mori, & Lopaschuk, 2014).  
Due to the low acetyl-CoA and energy generation under HF diet, the cell is most likely 
restoring homeostasis by gluconeogenesis. Positioned at the very center of carbon metabolism, 
the TCA cycle functions as a metabolite hub, receiving carbon flow from different substrates and 
redirecting them to gluconeogenesis (Satapati, et al., 2012). As is shown in Figure 8, pyruvate 
reduction was not significant in HF group, but aspartate, which is convertible with OAA, 
decreased significantly (p=091). Combining the latter results with the significant increase in 
phosphoenolpyruvate (PEP) (p=0.002), and trending, but insignificant increase in glycerate-3-
phosphate (3PG), glyceraldehyde-3-phosphate (GA3P) and glucose-1-phosphate (G1P), these 
changes indicates that HF group is undergoing mitochondria TCA anaplerosis from pyruvate to 
OAA followed by a cataplerosis from OAA to PEP (Sunny, Parks, Browning, & Burgess, 2011).  
Pyruvate is not the only source of TCA anaplerosis as elevated amino acid anaplerosis 
has been reported on multiple studies conducted with HF diet animal models (An, et al., 2013) 
(Boulangé, et al., 2013) (Zha, et al., 2009). As is shown in Figure 9, amino acid catabolism was 
also higher in the HF group in a significantly large and wide scale. Ketogenic lysine and branch 
chain amino acid (BCAA) including leucine, isoleucine and valine significantly decreased 
combined with a decreasing, but insignificant, trend in glycogenic glutamate, proline, ornithine,  
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threonine, glycine, serine and alanine. Other amino acids, including glutamine and aspartate also 
declined, albeit not significantly.  
These results indicate that carbon flowed from amino acids and entered into the TCA 
cycle at different points, such as α-ketoglutarate, succinyl-CoA, fumarate, OAA and acetyl-CoA, 
thereby significant increasing TCA intermediates, especially succinate and fumarate (Figure 9). 
Satapati et al. (2012), An et al. (2013), and Boulangé et al. (2013) also reported elevated TCA 
metabolites in the presence of a HF diet. Satapati et al. (2012) proposed that the cells are in 
relatively oxidized redox state accompanied by a slower TCA cycle rate thereby causing other 
metabolic complications. For example, elevated fumarate and succinate have been shown to 
inhibit HIF-1α prolyl hydroxylase, resulting in hypoxia-inducible factor 1-alpha (HIF-1α) protein 
accumulation, which, in turn, causes a pseudo hypoxic cellular response (Koivunen, et al., 2007) 
(Selak, et al., 2005).  
B. The impact of red grain sorghum crude lipid on central carbon metabolism in the 
presence of a HF diet 
i. Effect of GS-CL supplements on HF stressors: energy and redox balance 
Lee (2013) showed that lipids extracted from the whole kernel GS were able to modulate 
central carbon metabolism in both the liver and the large intestine of golden Syrian hamsters, but 
this study used fractioned oil and wax. In the current study, we show for the first time the impact 
that whole kernel GS-CL, that contains both the wax and oil fraction, has on cellular energy status 
in the presences of a HF diet. As is shown in Figure 10, energy charges obtained from three GS-
CL supplemented groups all increased significantly, with the highest positive change occurring in 
the 3% GS-CL supplemented animals. This benefit, however, is not completely does-dependent, 
as the 5% group did not recover as well as 3% group. Improved energy charge could be attributed 
by two possible reasons, motivated mitochondria TCA cycle or activated AMP activated protein 
kinase (AMPK) complex (Wang, et al., 2015) (Kang, et al., 2015). Although experiment have yet 
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to be conducted to determine AMPK activity, a motivated TCA cycle was indeed observed in GS 
supplemented groups, which will be discussed in next session.  
In terms of redox balance, the GS-CL was not able to reverse the low level of NAD+ and 
GSH caused by HF diet, GS-CL supplemented groups were not significantly different for either 
of these metabolites compared to the HF group (Figure 11A and Figure 12A). The metabolite, 
NADH remains nearly constant among all five groups (Figure 11B), yet there might be a slight 
upward trend in the NAD/NADH ratio to a ratio closer to the control occurred among the GS-CL 
supplemented groups in a dose dependent manner (Figure 11C).  
The improvement in the GSH/GSSG ratio (Figure 12C) produced by 1% supplemented 
diet is certainly evident. Interestingly, it was achieved by breaking down GSSG without a 
concomitant increase in GSH (Figure 12B). (Reduction of 1mole GSSG to 2 moles GSH is 
catalyzed by glutathione reductase at the expense of NADPH, which was oxidized to NADP+ 
(Lushckak, 2012)). Incidentally, NADP+ in 1% group was higher compared to other groups 
(Figure 13B), which could be the reason for the significant reduction of GSSG. The whereabouts 
of the regenerated GSH from GSSG after reduction is illusive. However, GSH may have been 
used to elevate the activity of glutathione S-transferase (GST) enzymes and increased GSH 
detoxification capacity (Lushckak, 2012), but more studies are needed to test this hypothesis.  
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Figure 10 Effect of GS-CL on cellular energy charge. Values are shown as the means ± SEM, n=11. Statistical analysis 
ANOVA and Tukey’s multiple comparison was conducted (***p≤0.001). 
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Other changes to metabolite redox couples may show additional insights into the cellular 
redox state (Figure 14). The malate-aspartate shuttle (MAS) and the glycerol-3-phosphate (G3P) 
shuttle are the primary and secondary pathways that are able to recycle glycolysis-generated 
cytosolic NADH back to NAD+. The shuttles are required because the mitochondrial inner 
membrane is impermeable to NADH (Easlon, Tsang, Skinner, Wang, & Lin, 2008). To 
circumvent this obstacle, malate and G3P transports the reducing equivalents into mitochondria 
(Easlon, Tsang, Skinner, Wang, & Lin, 2008), whereas the lactate/pyruvate couple recycles 
glycolytic NADH to NAD+ in the cytosol. Under normal aerobic condition, pyruvate enters the 
mitochondria for oxidative phosphorylation. In cases of hypoxia, mitochondria damages or 
elevated energy demand, however, pyruvate can also be reduced to lactate to facilitate NAD+ 
regeneration as a result of anaerobic respiration, or to compensate for the inability of MAS to 
keep pace with cytosolic NAD+ demand (Kane, 2014).  
As is shown in Figure 14, the HF group presented with a considerably higher ratio of 
malate/aspartate, glycerol-3P/DHAP and lactate/pyruvate, indicating that the relative content of 
the electron carriers, malate, G3P and lactate, are elevated. As such, the HF group is in a 
relatively oxidized cellular state with respect to the control. In contrast, the 1% and 3% 
supplemented diets were able to lower each of these ratios in a does dependent manner. 
Interestingly, the 5% group exhibited elevated levels of all three ratios comparable to or even 
higher than the HF group. Further investigation of HIF-1α or mitochondrial electron transport 
chain complexes needs to be completed in order to determine the exact cause behind the latter 
results as they are the indicators for possible hypoxia and mitochondria damages, respectively.  
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ii. Effects of GS-CL supplements on HF stressors: key carbon metabolic pathways 
 An overview of global changes caused by diet and GS-CL supplements is illustrated by 
PLS-DA based on all the metabolite changes (Table 3) collected from all five groups in both 2D 
and 3D score plot (Figure 15). The control and HF group are clearly separated with the 1% group 
positioned in the middle, indicating a protective ability of GS-CL. The 3% group scatters across 
1% and control group, representing the possibility of complete protection. Lastly, the 5% group is 
clustered further away from both the 1% and 3% groups but partially overlaps with HF group, 
further indicating that higher doses of GS-CL are less effective in modulating energy metabolism 
caused by a HF diet. 
The three GS-CL supplement groups were analyzed via targeted metabolomics and 
compared with both HF and control groups using an OPLS-DA approach (shown in appendix), 
which in turn were summarized, as depicted in Figure 16. For the 1% GS-CL, the majority of 
elevated TCA metabolites caused by the HF diet were reduced back to the range of control group, 
i.e., malate (from 0.349 ± 0.041 µMol/g to 0.192 ± 0.027 µMol/g), fumarate (from 0.098 ± 0.011 
µMol/g to 0.044 ± 0.007 µMol/g), and succinate (from 1.015 ± 0.488 µMol/g to 0.370 ± 0.128 
µMol/g). It must be noted however, that citrate was not affected by the 1% GS-CL supplement. In 
addition, the 1% supplement was not able to stop the anaplerosis flow from pyruvate and amino 
acids caused by the HF diet. Pyruvate continued to decrease from 0.031 ± 0.006 µMol/g in HF 
group to 0.023 ± 0.002 µMol/g, while all the amino acids measured were even lower for 1% 
group compared to the HF animals. The anaplerosis flow for the 1% group is most likely slower 
than HF group as 3PG, GA3P and G1P are all lower, while PEP maintained the same level as HF 
group. In addition, the net content of acetyl-CoA (0.015 ± 0.000 µMol/g) is significantly lower 
than both control (0.032 ± 0.002 µMol/g) and HF groups (0.031 ± 0.003 µMol/g), implying that 
cells are still relying on fatty acid β oxidation as the main and slow energy source. Interestingly, 
glycerol-3-phosphate (G3P) decreased for the 1% group, indicating that the supplement may have 
the ability to restrict de novo triglyceride synthesis. These results concurs with the decreased   
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plasma triglycerides demonstrated by Althwab (2016). Specifically, the plasma triglyceride levels 
were reduced by 35% in hamsters fed with 1% red GS-CL supplemented HF diets compared with 
HF diet alone (Althwab, 2016).  
By increasing the GS-CL supplement to 3%, the beneficial effects became more evident. 
Not only were the TCA metabolites malate (0.227 ± 0.025 µMol/g), fumarate (0.055 ± 0.008 
µMol/g) and succinate (0.429 ± 0.214 µMol/g) as low as that of the 1% and control diets, but 
gluconeogenesis and anaplerosis flow slowed down prominently as well (Figure 16). Although 
pyruvate (0.024 ± 0.002 µMol/g) for the 3% group remained as low as 1% group, many of the 
amino acids were considerably higher than the HF group. Still, others, such as tyrosine, glutamate 
and glutamine, were restored completely similar to the low fat diet. Moreover, the glycolytic 
metabolites, 3PG, GA3P and G1P, decreased significantly to the level of the control group. Also 
G3P continued to decline in 3% group, suggesting a lasting restraining effect on triglyceride 
synthesis. Finally, acetyl-CoA (0.019 ± 0.001 µMol/g) started to recover in 3% group. Combined 
with slightly elevated citrate, these results indicate that the energy source begins to switch from 
fatty acid β oxidation back to glucose when a HF diet is consumed in the presence of 3% (w/w) 
GS lipid diet. 
The 5% diet provides interesting and unexpected metabolic differences to both the 1% 
and 3% diets. Similar to the two lower GS-CL supplement doses, the 5% diet was able to sustain 
lower TCA metabolites, i.e., malate (0.208 ± 0.024 µMol/g), fumarate (0.060 ± 0.010 µMol/g) 
and succinate (0.124 ± 0.044 µMol/g). This diet also improved most of the amino acids levels 
relative to the 1% group. Some amino acids, such as alanine, serine and glycine, were restored 
completely, which was not achieved by the 3% group. Interestingly, however, the glycolytic 
metabolites 3PG and GA3P continued to decline with the noticeable exception of PEP (0.031 ± 
0.003 µMol/g). The level of this intermediate was the highest among all five groups, suggesting 
accumulation of PEP. Moreover, lactate and G3P both spiked in 5% group, indicating that the cell 
is routing pyruvate toward lactate instead of the TCA cycle while directing the glycolytic sugar 
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phosphates toward triglyceride synthesis. In addition, acetyl-CoA (0.013 ± 0.001 µMol/g) 
reversed its upward trend exerted by the 3% diet, but rather was the lowest among the five 
groups. Based on this data, the 5% diet restricted the carbon flow from entering the TCA cycle, 
and channeled it towards lactate and triglycerides synthesis.  
Overall, the 3% supplement diet was able to attenuate the damage on carbohydrate 
metabolism inflicted by HF diet with most of its metabolites approach values exhibited by the 
control group. The 3% diet was also able to stop the gluconeogenesis and anaplerosis from 
pyruvate and amino acids, motivated the TCA cycle and reduced the reliance of the cells on fatty 
acids. On the other hand, the 1% supplement diet was able to maintain a motivated TCA cycle, 
although the gluconeogenesis and anaplerosis was not halted. The 1% diet was not able to 
completely restore the deteriorating effect of a HF diet, but it did halt some of the changes in 
central metabolism. Lastly, the 5% GS-CL terminated anaplerosis from amino acids. However, 
carbon flow was restricted from entering the TCA cycle, which may due to the possible 
mitochondria damages caused by the increased fat burden of the 5% lipid supplement. Instead, 
this diet directed the carbon flow toward lactate and triglyceride synthesis.   
III. Specific aim 2: GS-CL supplements modulate short chain fatty acid 
profile produced by gut microbiota 
Short chain fatty acids (SCFA) are volatile fatty acids produced by gut microbiota in 
colon as fermentation products. These molecules are characterized by containing fewer than six 
carbons, existing in straight and branched-chain formation, among which, acetate (C2), propionate 
(C3) and butyrate (C4) are the most abundant, representing 90% of the SCFA present in the colon 
(Ríos-Covián, et al., 2016). The biological effects of SCFA was reviewed in detailed by Ríos-
Covián et al. (2016). More specifically, both butyrate and propionate have been reported to exert 
prominent effects in reducing inflammation and other diet-induced stressors, such as HF diets.  
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For example, Jakobsdottir et al. (2013) demonstrated that a HF diet reduces the formation of 
SCFA on the whole and butyrate in particular in rats. In addition, the abundance of acetate-
producing bacteria was increased in response to chronic HF diet consumption (Lecomte, et al., 
2015).  
The diet can also positively affect the gut microbiota composition and activity, and 
therefore the profile of synthesized SCFA (Brüssow & Parkinson, 2014). One such diet consists 
of high fiber and low fat diet, which has been characterized by higher levels of fecal SCFA 
(Cuervo, Salazar, Ruas-Madiedo, Gueimonde, & González, 2013). In the current experiment, the 
change in gut microbiota profile has yet to be determined, but the concentration of three most 
abundant SCFA was analyzed in five diet groups. The amount of acetate in HF and 5% 
supplement groups increased dramatically, over 10-fold higher compared to the control, 1% and 
3% supplement groups (Figure 17A). Although butyrate was not detected in HF and 5% 
supplement groups, 1% and 3% supplement groups did produce a dose-dependent recovery in 
butyrate. Still, the latter two dosages were not able to completely remediate the effects caused by 
the HF diet as butyrate levels were higher in the control group (Figure 17B). For propionate, all 
HF groups with or without GS-CL supplement were lower compared to the control group. It is 
further noticeable that the 5% group presented with even lower levels of propionate than the HF 
group (Figure 17C).  
Based on the data, the 3% GS-CL supplement demonstrated the optimal protection of the 
SCFA profile against HF-induced stress followed by the 1% supplement. The 5% supplement 
group did not show any improvement when compared to HF group. This trend is also exemplified 
in the acetate: propionate ratio (Figure 17D). As acetate is a substrate involved in cholesterol 
synthesis via acetyl-CoA, it is generally preferable to have a low acetate: propionate ratio 
(Jakobsdottir, Xu, Molin, Ahrné, & Nyman, 2013). The 1% and 3% supplement groups showed a 
low acetate: propionate ratio comparable to the control group whereas 5% supplement group is 
comparable to the HF group.   
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Figure 17 Effect of GS-CL on short chain fatty acid profile. Values are shown as the means ± SEM, n=11. Statistical 
analysis ANOVA and Tukey’s multiple comparison was conducted (***p≤0.001). 
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IV. Specific aim 3: Characterization of red grain sorghum (sorghum 
bicolor) whole kernel crude lipid 
A. Characterization of red GS-CL 
Determination of the whole kernel red GS-CL showed yields of 0.2-0.4% on a dry weight 
basis, which is similar to that reported by Hwang et al. (2004). Christiansen (2008) produced a 
higher yield (0.6%), but a solvent to solid ratio of 3:1 was employed compared to the 1:1 ratio 
used in this study, which may have caused the yield variability. For example, total lipid yield is 
influenced by the method of its extraction  (Christiansen K. , Weller, Schlegel, & Dweikat, 2008). 
However, for GS, the difference of extraction method is only significant for the ground GS and 
GS-DDGS, indicating that the lipid yield of whole kernel GS is not affected by the method of 
extraction (Leguizamón, Weller, Schlegel, & Carr, 2009). In addition, Leguizamón (2009) 
showed that the form of GS is substantially affects lipid yields. Lipid yields obtained of GS-
DDGS was higher lipid compared to either ground or whole kernel GS as the non-starch 
compounds are concentrated after fermentation. Although ground GS does not produce as much 
lipid as GS-DDGS, ground GS yields higher amount of lipid compared to the whole kernel GS 
due to increased surface area. Indeed, Hwang et al. (2004) reported a lipid yield of 0.5-0.6% from 
GS-DDG, much higher than the yield of 0.2-0.3% from GS whole kernel.  
Further characterization of the red whole kernel lipid, as depicted by TLC (Figure 
18),showed the presence of monoacylglycerols, diacylglycerols, triacylglycerols, fatty acids, fatty 
aldehydes, fatty alcohols (policosanols), free sterols (phytosterols), wax/steryl easters and 
hydrocarbons. These results concur with the TLC analysis reported by Carr et al. (2005).  
Among TLC shown lipid categories, phytosterols and policosanols are of particular 
interest due to their many health benefiting effects, including cholesterol management, improving 
blood lipid profile and anti-cancer (Carr, Ash, & Brown, 2010) (Awad & Fink, 2000) (Gouni-
Berthold & Berthold, 2002). For the whole kernel red GS-CL, phytosterols were present at 4.93 ±  
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Figure 18 The simple lipid profile of GS-CL analyzed by thin layer chromatography (TLC). Lipid was spotted on silica 
plate and developed with hexane: diethyl ether: acetic acid (85:15:2, by volume). The plate was visualized by 
submerged briefly in 10% cupric sulfate, 8% phosphoric acid solution, air-drying in a chemical fume hood before 
charring in an oven at 165°C for 10min. 
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0.05 mg/g lipid total phytosterols with β-sitosterol being the most abundant (58.7%), followed by 
campesterol (24.3%) and stigmasterol (16.9%) (Table 3). These results were slightly higher than 
the 3.48 mg/g lipid and 2.98 mg/g lipid reported by Carr et al. (2005) and Leguizamón et al. 
(2009), respectively. In addition, the prevalence of these three phytosterols is supported by a 
study performed by Leguizamón et al. (2009). However, Christiansen (2007) reported that 
stigmasterol was the most abundant phytosterol in whole kernel lipid extracts of nine different 
parent lines of GS, which was probably due to the co-elution between stigmasterol and 
triacontanol (C30). In addition, extraction time and method (Winkler, Rennick, Eller, & Vaughn, 
2007), and hydrolysis and saponification during sample preparation (Piironen, Toivo, & Lampi, 
2002) can also affect the yield of phytosterols.  
The level of total policosanols in red GS-CL was 15.61 ± 0.6 mg/g with octacosanol (C28) 
(50.9%) and hexacosanol (C26) (40.4%) being the major components. It must be emphasized that 
the extracts obrained from the red whole kernel GS contained higher policosanols compared to 
8mg/g lipid measured by Carr et al. (2005), but lower compared to 18.82 mg/g lipid measured by 
Leguizamón et al. (2009). Although Leguizamón et al. (2009) also reported high levels of 
octacosanol (51.5%) and hexacosanol (24.5%), they detectedonly 21.2% of triacontanol (C30) and 
very little of dotriacontanol (2.8%). Similar to that of the total lipid, the yield of policosanols are 
much higher from GS-DDG than that of GS whole kernel (Hwang, Weller, Cuppett, & Hanna, 
2004). Policosanols, mostly long-chain fatty acids, tend to remain intact during the ethanol 
fermentation process, hence are likely concentrated in DDG form. Interestingly, Hwang et al. 
(2004) also reported fairly high percentage of triacontanol (C30, 40-43%) yield.  
Similar to other cereal groups, triacylglycerols is one of the most abundant lipid classes 
present in whole kernel GS lipid extract (Lee, et al., 2011). Fatty acid analysis showed that 
linoleic acid, oleic acid and palmitic acid are the predominant fatty acid classes in whole kernel 
red GS-CL (Figure 19), together comprising up to 88.8% fatty acids. Carr et al. (2005) reported   
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Table 3 Other composition of GS-CL. 
Compound Composition Content 
Phytosterols1 
Total amount (mg/g lipid) 4.93 ± 0.05mg 
β-Sitosterol 58.7% 
Stigmasterol 16.9% 
Campesterol 24.3% 
Policosanols1 
Total amount (mg/g lipid) 15.61 ± 0.6mg 
Hexacosanol (C28) 40.4% 
Octacosanol (C26) 50.9% 
Dotriacontanol (C32) 8.7% 
Vitamin E2 
As mg α-Tocopherol per g 
lipid 
0.068 ± 0.007mg 
Carotenoids3 Total amount (µg/g lipid) 0.77 ± 0.04µg 
Tannins4 As mg catechin per g lipid 0.278 ± 0.008mg 
1 Phytosterols and policosanols were determined by GC-FID as described by Leguizamón et al. (2009);  
2 α-Tocopherols was analyzed by a spectrophotometer as described by Wong et al. (1988); 
3 Carotenoids were determined by a spectrophotometer as described by Lichtenthaler & Buschmann (2001);  
4 Tannins were determined by a spectrophotometer as described by Bhat et al. (2007).  
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Figure 19 The fatty acid profile of GS-CL. Fatty acids were analyzed by GC-FID after methylation as described by 
Metcalfe et al. (1966). Percentage results from the cited compositional analyses are based on relative amounts. 
  
Palmitic Acid 
(C16:0)
20%
Steric Acid 
(C18:0)
4% Myristic Acid 
(C14:0)
2%
Linolenic Acid 
(C18:3)
2%
Eicosanoic Acid 
(C20)
1%Palmitoleic Acid 
(C16:1)
1%
Linoleic Acid 
(C18:2)
35%
Oleic Acid (C18:1)
35%
61 
 
 
 
similar fatty acid composition of 17% palmitic acid, 35% oleic acid and 41% linoleic acid. 
Christiansen (2006) noted that the lipid extract from ground GS contains more triacylglycerols 
and diacylglycerols while whole kernel GS lipid extract contains more policosanols and 
phytosterols. These results indicates that the health benefiting policosanols and phytosterols are 
located mainly in the coating lipid covering the kernel surface.  
In addition, micronutrients, including carotenoids, tocopherols and tannins were also 
determined. The whole kernel GS-CL contains 0.068 mg/g lipid tocopherols, higher than the two 
GS parent lines studied by Christiansen (2007) (21.9 mg and 57.7 mg per 100 g lipid). Also, the 
red GS-CL contains 0.278 mg/g lipid tannins. Most of the GS cultivated in the US are tannin-free 
due to their impact on the digestibility of many nutrients, but the selected red GS in this study 
contains high tannin for the purpose of studying their part in the health benefiting effect of GS 
lipid extract. Lastly, the whole kernel GS-CL contains 0.77 µg/g lipid carotenoids.  
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B. Possible links between red GS-CL composition and its effects on central carbon 
metabolism 
The health promoting properties of bioactive compounds are connected to its 
composition. The effects of red GS-CL on central carbon and energy metabolism discussed in 
previous chapter reflect the combined effects of each component and the additive, synergistic or 
antagonizing interactions among them. The major bioactive components in GS-CL, such as 
phytosterols and policosanols, exert their own effect on central carbon metabolism, although 
metabolic studies of these individual components remains limited as research on phytosterols and 
policosanols are mainly focusing on its regulation on cholesterol and lipid metabolism (Carr, Ash, 
& Brown, 2010)  (Gouni-Berthold & Berthold, 2002). Nevertheless, Lee et al. (2015) showed that 
barley sprout extracts (BSE) containing 5.74 mg/g policosanols affected hepatic glucose 
metabolism in HF diet fed C57BL/6J mice model. The BSE supplement reduced fasting glucose 
level by repressing hepatic gluconeogenesis genes, including fructose-1,6-biphosphatase and 
pyruvate carboxylase (Lee, et al., 2015). Researchers further concluded that the activation of 
AMPK was responsible for this repression. In addition, aloe vera phytosterol extracts suppressed 
hyperglycemia and lowered both basal and fasting blood glucose levels in obese diabetic Zucker 
rats  (Misawa, et al., 2008). The phytosterol extracts repressed gluconeogenesis by lowering the 
expressions of glucose-6-phosphatase and phosphoenolpyruvate carboxylase (PEPCK) and 
promoted glycolysis by increasing the mRNA level of glycolysis enzyme glucokinase (GK) 
(Misawa, et al., 2012). This beneficial effects of phytosterols in glucose metabolism can also be 
traced back to its role in activating AMPK (Hwang, et al., 2008).  
In the current study, gluconeogenesis caused by HF diet was partially mitigated by GS-
CL, especially in 3% GS-CL supplement group. Although the gene expression of pyruvate 
carboxylase and PEPCK, which catalyze the gluconeogenic conversion of pyruvate to OAA and 
OAA to PEP, respectively, have yet to be measured in this study, the suppression on 
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gluconeogenesis by 1% and 3% GS-CL was evident by an increase in pyruvate and an decrease in 
PEP. In addition, decreases in GA3P and 3PG presented by the supplemented groups indicated 
that the rate of glycolysis was partially restored by GS-CL. Kim and Park (2012) have showed 
that sorghum ethanol extract increases the phosphorylation of AMPK in streptozotocin-induced 
diabetic rats. It is therefore possible that the results in the current experiment is connected to the 
policosanols and phytosterols in GS-CL, which regulate the key gluconeogenesis and glycolysis 
enzymes by activating of AMPK.  
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5. Conclusion and future studies 
Grain sorghum is a widely cultivated yet critically underutilized crop in the US. The 
crude lipid located on the surface of the whole kernal is of particular interest due to its unique 
phytochemical profile and beneficial regulatory effects on plasma and liver cholesterol and gut 
microbiota. In order to explore its impact on cellular central carbon and energy metabolism, GS-
CL was supplemented to a HF diet in 1, 3 and 5% dosage and fed to a hamster model for 4 weeks 
period in comparison to a normal control diet and a HF diet.  
The HF diet alone caused severe impairment in the ability of a cell to generate energy and 
disrupted cellular redox balance in hamster large intestine. The excessive fat supply forced the 
cells to reprogram its central carbon metabolism to use fat instead of glucose as the major energy 
source in order to accommodate excessive fat and compensate for the insufficient glucose supply. 
Many of amino acids as well as pyruvate are depleted greatly substantially when a system is in a 
gluconeogenesis state. These compounds thus enter the TCA cycle from different point, resulting 
in accumulated TCA cycle intermediates and elevated glycolytic intermediates.  
The GS-CL supplements was able to restore the ability of the cells to generate energy as 
energy charges obtained from three GS-CL supplemented groups all increased significantly. 
However, they were not able to completely restore the redox balance disrupted by the HF feeding 
as GSH and NAD+ levels were as low as HF group. Yet slight upward trend in NAD+/NADH 
and GSH/GSSG ratios occurred possibly showing a long term protective effect based on feeding 
time or dosage levels. Multivariant analysis showed that the 3% supplement diet was the optimal 
diet in terms of protecting against damages to central carbon metabolism inflicted by HF diet by 
activating the TCA cycle and glycolysis as well as suppressing gluconeogenesis similar to that 
exerted by a low fat diet. The 1% supplement diet was not able to suppress anaplerosis from 
amino acids but gluconeogenesis was halted and the TCA metabolic rate increased. The 5% 
supplement diet was able to suppress anaplerosis from amino acids and motivate the TCA cycle, 
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but resulted in increasing gluconeogenesis, most likely due to contributing to the overall fat 
content. As a result, carbon flow towards lactate and triglyceride synthesis increased. For SCFA 
production in response to GS-CL dosage levels, the 5% supplemented diet performed similar to 
the HF diet while the 1% and 3% supplemented diets produced SCFA levels similar levels to the 
control diet.  
Results obtained from the current study should be used as a stepping stone, upon which 
new theories and hypothesis can be built. In this study, cellular energy generation was severely 
impaired by the HF diet, resulting in a considerably low energy charge in that group. Cellular 
redox balance was also disrupted by the HF diet presented by a significantly lower NAD/NADH 
ratio. It is possible that the excessive fat from the HF diet accumulated in mitochondria for β 
oxidation, which damages the electron transport chain, thereby reduces the ability of the cells to 
generate energy and recycle NADH. Analysis regarding the activity of electron transport chain 
needs to be performed. In addition, elevated TCA cycle intermediates fumarate and succinate in 
the HF group could lead to HIF-1α protein accumulation. As a transcription factor, HIF-1α binds 
to nuclear, signaling a pseudo hypoxic cellular response (Koivunen, et al., 2007) (Selak, et al., 
2005) and possibly initiate inflammation. Quantitative analysis of HIF-1α protein and pro-
inflammatory cytokine NF-κB and TNF-α are needed in order to understand the mechanism. 
Moreover, the impact of GS-CL on SCFA profile is not fully understood until microbiome study 
is performed on the fecal samples collected from all five groups. The GS-CL probably regulated a 
single or multiple species in the gut microbiome resulting in the changes shown in SCFA profile. 
The metabolic impact of GS-CL can be traced back to its composition. The red GS-CL 
used in this experiment contained high levels of phytosterols and policosanols, both of which 
have shown promoting effects on glycolysis and suppressing effects on gluconeogenesis by 
activating the AMPK in the cell (Lee, et al., 2015) (Misawa, et al., 2012). Moreover, it is possible 
that the GS-CL improved cellular energy state through activating AMPK because improved 
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energy state can be attributed to AMPK activation (Wang, et al., 2015) (Kang, et al., 2015). The 
phosphorylation and activity of AMPK need to be analyzed in all five groups, which will assist 
understanding how the GS-CL protect the cells against HF induced damages on central carbon 
metabolism, the connection between its composition and function.  
Lee (2013) fractioned white GS-CL into oil and wax, and determined that the 
phytosterols and policosanols are present in the oil and wax fraction, respectively. Both fractions 
were then administered to each HF diet hamster model. Metabolic analysis of the intestinal tissue 
show different impacts exerted by the two fraction groups (Lee, 2013). Therefore, it is 
recommended that red GS-CL can also be separated into oil and wax fractions to understand how 
each may reprogram cellular central metabolism differently compared to either the red GS-CL or 
white GS fractions. The possible synergistic, antagonizing or simple additive interactions 
between the two fractions may well further our understanding towards this novel healthy 
promoting extract.   
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